A phase III study in adenocarcinoma patients showed higher probability of pCR and tumor-free lymph nodes at resection, with sequential treatment as compared with preoperative chemotherapy alone, as well as a trend towards a survival advantage that did not reach statistical significance ( 26 ).
1
—
—